Histogen's method of generating multipotent stem cells receives US patent

Main Category: Stem Cell Research Also Included In: Regulatory Affairs / Drug Approvals Article Date: 05 Sep 2013 - 2:00 PDT Histogen, Inc., a regenerative medicine company developing innovative therapies for conditions including hair loss and cancer , has announced that the United States Patent & Trademark Office has issued patent 8,524,494, ... (more)

http://www.medicalnewstoday.com/releases/265684.php